|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Noncash stock-based compensation expense | |||||
| Amortization of ROU assets | |||||
| Depreciation and amortization | |||||
| Amortization of prepaid assets | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaids and deposits | |||||
| Prepaid and deposits | |||||
| ROU liabilities | |||||
| Due to related parties | |||||
| Deferred revenue | |||||
| Accounts payable | |||||
| Accrued expenses and compensation | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Purchase of equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from note payable | |||||
| Proceeds from issuance of prefunded warrants | |||||
| Proceeds from the exercise of stock options and warrants | |||||
| Repayment on note payable | |||||
| Tax withholdings related to net share settlement of RSU’s | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing activities | |||||
| Insurance financing for prepaid insurance | |||||
| Implementation of ASC 842 | |||||
Loading...
